Phosphatidylethanolamines as biomarkers of e-cigarette or vaping product use-associated lung injury
- PMID: 35488453
- PMCID: PMC11305483
- DOI: 10.1002/ppul.25951
Phosphatidylethanolamines as biomarkers of e-cigarette or vaping product use-associated lung injury
Conflict of interest statement
CONFLICT OF INTEREST
The author declares no conflict of interest.
Similar articles
-
Reduced plasma phosphatidylethanolamines in e-cigarette, or vaping, product use-associated lung injury (EVALI).Pediatr Pulmonol. 2022 May;57(5):1350-1354. doi: 10.1002/ppul.25874. Epub 2022 Mar 9. Pediatr Pulmonol. 2022. PMID: 35233972 Free PMC article. No abstract available.
-
E-cigarette or Vaping Product Use-Associated Lung Injury Produced in an Animal Model From Electronic Cigarette Vapor Exposure Without Tetrahydrocannabinol or Vitamin E Oil.J Am Heart Assoc. 2020 Sep 15;9(18):e017368. doi: 10.1161/JAHA.120.017368. Epub 2020 Sep 8. J Am Heart Assoc. 2020. PMID: 32896206 Free PMC article.
-
Nicotine vaping was not the cause of e-cigarette, or vaping, product use-associated lung injury in the United States.Drug Alcohol Rev. 2023 Feb;42(2):258-261. doi: 10.1111/dar.13533. Epub 2022 Aug 23. Drug Alcohol Rev. 2023. PMID: 36000177 No abstract available.
-
Vaping and Lung Inflammation and Injury.Annu Rev Physiol. 2022 Feb 10;84:611-629. doi: 10.1146/annurev-physiol-061121-040014. Epub 2021 Nov 1. Annu Rev Physiol. 2022. PMID: 34724436 Free PMC article. Review.
-
E-Cigarette or Vaping Product-Associated Lung Injury: A Review.Am J Med. 2020 Jun;133(6):657-663. doi: 10.1016/j.amjmed.2020.02.004. Epub 2020 Mar 13. Am J Med. 2020. PMID: 32179055 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical